Catalyst Wire Dossier Catalyst Wire Dossier

KEVZARA

sarilumab · Sanofi-Aventis U.S. LLC
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for KEVZARA, covering 2016-03-28 to 2026-02-20. Get the full timeline:

Most recent: EMA Authorised: Kevzara (sarilumab) — Sanofi Winthrop Industrie

See pricing